<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE
        </div>
        <div class="card-body">
                <p>Background &lt;BR/&gt;Glioblastoma (GBM) is the most common primary brain tumor in adults with a median survival of approximately 15 months, therefore, more effective treatment options for GBM are required. To identify new drugs targeting glioblastomas, we performed a high throughput drug screen using patient-derived neurospheres cultured to preferentially retain their glioblastoma stem cell (GSC) phenotype. &lt;BR/&gt;Results&lt;BR/&gt;We found that GSCs were highly sensitive to proteasome inhibition due to an underlying dependency on an increased protein synthesis rate, and loss of autophagy, associated with PTEN loss and activation of the PI3K/mTOR pathway. In contrast, combinatory inhibition of autophagy and the proteasome, resulted in enhanced cytotoxicity specifically in GSCs that did express PTEN. Finally, proteasome inhibition specifically increased cell death markers in3D glioblastoma organoids, suppressed tumor growth, and increased survival of mice orthotopically engrafted with GSCs. As perturbations of the PI3K/mTOR pathway occur in nearly 50% of GBMs, these findings suggest that a significant fraction of these tumors could be vulnerable to proteasome inhibition.&lt;BR/&gt;Conclusions&lt;BR/&gt;Proteasome inhibition is a potential synthetic lethal therapeutic strategy for GBM with proteasome addiction due to a high protein synthesis rate and autophagy deficiency</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M40000">M40000</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:6659">ncbigene:6659</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:83667">ncbigene:83667</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6449">ncbigene:6449</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6664">ncbigene:6664</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:93436">ncbigene:93436</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:80174">ncbigene:80174</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:547">ncbigene:547</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3156">ncbigene:3156</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10137">ncbigene:10137</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6502">ncbigene:6502</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:53635">ncbigene:53635</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23258">ncbigene:23258</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2033">ncbigene:2033</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7465">ncbigene:7465</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:90007">ncbigene:90007</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51514">ncbigene:51514</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3091">ncbigene:3091</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23089">ncbigene:23089</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3658">ncbigene:3658</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4084">ncbigene:4084</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:158427">ncbigene:158427</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10982">ncbigene:10982</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:25793">ncbigene:25793</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4595">ncbigene:4595</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:595">ncbigene:595</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1719">ncbigene:1719</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:694">ncbigene:694</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:54707">ncbigene:54707</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:387082">ncbigene:387082</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:55924">ncbigene:55924</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6613">ncbigene:6613</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1856">ncbigene:1856</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7157">ncbigene:7157</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8079">ncbigene:8079</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51122">ncbigene:51122</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10916">ncbigene:10916</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10957">ncbigene:10957</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23326">ncbigene:23326</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1613">ncbigene:1613</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:55668">ncbigene:55668</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:166">ncbigene:166</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4783">ncbigene:4783</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:440">ncbigene:440</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:54859">ncbigene:54859</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51133">ncbigene:51133</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:11057">ncbigene:11057</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:56905">ncbigene:56905</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:112858">ncbigene:112858</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M40000&#39;, name=&#39;BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE&#39;), definition=&#39;Background &lt;BR/&gt;Glioblastoma (GBM) is the most common primary brain tumor in adults with a median survival of approximately 15 months, therefore, more effective treatment options for GBM are required. To identify new drugs targeting glioblastomas, we performed a high throughput drug screen using patient-derived neurospheres cultured to preferentially retain their glioblastoma stem cell (GSC) phenotype. &lt;BR/&gt;Results&lt;BR/&gt;We found that GSCs were highly sensitive to proteasome inhibition due to an underlying dependency on an increased protein synthesis rate, and loss of autophagy, associated with PTEN loss and activation of the PI3K/mTOR pathway. In contrast, combinatory inhibition of autophagy and the proteasome, resulted in enhanced cytotoxicity specifically in GSCs that did express PTEN. Finally, proteasome inhibition specifically increased cell death markers in3D glioblastoma organoids, suppressed tumor growth, and increased survival of mice orthotopically engrafted with GSCs. As perturbations of the PI3K/mTOR pathway occur in nearly 50% of GBMs, these findings suggest that a significant fraction of these tumors could be vulnerable to proteasome inhibition.&lt;BR/&gt;Conclusions&lt;BR/&gt;Proteasome inhibition is a potential synthetic lethal therapeutic strategy for GBM with proteasome addiction due to a high protein synthesis rate and autophagy deficiency&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;33428749&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6659&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;83667&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6449&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6664&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;93436&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;80174&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;547&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3156&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10137&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6502&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;53635&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23258&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2033&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7465&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;90007&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51514&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3091&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23089&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3658&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4084&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;158427&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10982&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;25793&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4595&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;595&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1719&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;694&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;54707&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;387082&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;55924&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6613&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1856&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7157&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8079&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51122&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10916&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10957&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23326&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1613&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;55668&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;166&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4783&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;440&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;54859&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51133&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;11057&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;56905&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;112858&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Anthony Castanza&#39;], &#39;exact_source&#39;: [&#39;noab001_suppl_Supplementary_Table_S3 PIRLE, CORE ENRICHMENT = YES&#39;], &#39;external_details_url&#39;: [&#39;https://doi.org/10.1093/neuonc/noab001&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>